TTY Biopharm Company Limited (TPEX:4105)
Taiwan · Delayed Price · Currency is TWD 76.90
+0.40 (0.52%)
Sep 8, 2026, 1:30 PM CST
TTY Biopharm Company Market Cap
TTY Biopharm Company has a market cap or net worth of 19.02 billion as of September 4, 2026. Its market cap has decreased by -1.80% in one year.
Market Cap
19.02B
Enterprise Value
18.94B
Revenue
6.65B
Ranking
n/a
PE Ratio
10.99
Stock Price
76.90
ChartMarket Cap Chart
Since July 3, 2003, TTY Biopharm Company's market cap has increased from 3.05B to 19.02B, an increase of 523.83%. That is a compound annual growth rate of 8.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 19.02B | -6.13% |
| Dec 31, 2025 | 20.26B | 11.95% |
| Dec 31, 2024 | 18.10B | -9.45% |
| Dec 29, 2023 | 19.99B | -3.60% |
| Dec 30, 2022 | 20.74B | 21.22% |
| Dec 30, 2021 | 17.11B | 0.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 52.95B |
| Lotus Pharmaceutical | 49.08B |
| Center Laboratories | 23.85B |
| Handa Pharmaceuticals | 17.47B |
| Synmosa Biopharma | 16.08B |
| ScinoPharm Taiwan | 15.10B |
| YungShin Global Holding | 14.94B |
| Grape King Bio | 13.41B |